Analyst firms · BofA Securities · HUM

BofA Securities HUM price target and rating history

Humana Inc. (HUM) · Health Care

BofA Securities rates Humana Inc. (HUM) Buy with a $500 price target, as of its latest action on Jul 29, 2026. It has published 6 rating actions on HUM since November 2023, including 2 upgrades and 4 downgrades. Across 12 firms with a HUM price target in the last 12 months, the median target is $501. BofA Securities's target matches it.

Current rating
Buy
Price target
$500
Median target, all firms
$501
Actions on HUM
6

BofA Securities price target on HUM

$500$253$6.50202420252026
BofA Securities price target on HUM, each point a stated target, November 2023 to July 2026.

Every BofA Securities rating on HUM

How other firms rate HUM

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
RBC Capital MarketsOutperform$563Nov 16, 2026
Raymond JamesOutperform$520Oct 12, 2026
Robert W. BairdOutperform$596Oct 9, 2026
Cantor FitzgeraldOverweight$460Oct 7, 2026
BarclaysOverweight$515Sep 25, 2026
Morgan StanleyEqual-Weight$370Aug 5, 2026
Evercore ISIOutperform$480Jul 30, 2026
Leerink PartnersOutperform$513Jul 30, 2026
BofA SecuritiesBuy$500Jul 29, 2026
Wells FargoOverweight$502Jul 13, 2026
Deutsche BankBuy$441May 20, 2026
JefferiesBuy$313Dec 5, 2025

Questions about BofA Securities and HUM

What is BofA Securities's price target for HUM?
BofA Securities's latest stated price target for Humana Inc. (HUM) is $500, from its action on Jul 29, 2026.
What is BofA Securities's rating on HUM?
BofA Securities rates HUM Buy, a bullish rating, as of Jul 29, 2026.
When did BofA Securities last change its view on HUM?
On Jul 29, 2026, BofA Securities upgrades to Buy from Neutral, price target $500.
How does BofA Securities's HUM target compare with other analysts?
Across 12 firms with a HUM price target in the last 12 months, the median target is $501. BofA Securities's target matches it.

More HUM rating histories

All BofA Securities ratingsHUM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.